Jacobio Pharmaceuticals Group Co., Ltd. (HKG:1167)
Hong Kong
· Delayed Price · Currency is HKD 6.80
+0.67 (10.93%)
Mar 10, 2026, 3:04 PM HKT
HKG:1167 Revenue
Jacobio Pharmaceuticals Group had revenue of 45.66M CNY in the half year ending June 30, 2025, with 13.21% growth. This brings the company's revenue in the last twelve months to 201.37M, up 768.54% year-over-year. In the year 2024, Jacobio Pharmaceuticals Group had annual revenue of 155.71M with 145.13% growth.
Revenue (ttm)
201.37M CNY
Revenue Growth
+768.54%
P/S Ratio
21.85
Revenue / Employee
954.37K CNY
Employees
211
Market Cap
4.82B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Viva Biotech Holdings | 2.01B |
| Shandong Boan Biotechnology | 829.27M |
| Mirxes Holding Company | 166.32M |
| Laekna | 5.07M |
| TYK Medicines | 117.25K |
| Ocumension Therapeutics | 595.79M |
| Qyuns Therapeutics | 351.04M |
| CARsgen Therapeutics Holdings | 139.84M |